2-[(8R,11S,14S,17S,20S,23S,26S,32S,35S)-8-acetamido-35-carbamoyl-14,17-bis[(5-fluoro-1H-indol-3-yl)methyl]-23-(1H-imidazol-4-ylmethyl)-26-[(4-methoxyphenyl)methyl]-11,32-dimethyl-9,12,15,18,21,24,27,33-octaoxo-2,3,4,10,13,16,19,22,25,28,34-undecazatetracyclo[35.2.2.12,5.028,32]dotetraconta-1(40),3,5(42),37(41),38-pentaen-20-yl]acetic acid

C68H75F2N17O13 — CID 166611943

IUPAC2-[(8R,11S,14S,17S,20S,23S,26S,32S,35S)-8-acetamido-35-carbamoyl-14,17-bis[(5-fluoro-1H-indol-3-yl)methyl]-23-(1H-imidazol-4-ylmethyl)-26-[(4-methoxyphenyl)methyl]-11,32-dimethyl-9,12,15,18,21,24,27,33-octaoxo-2,3,4,10,13,16,19,22,25,28,34-undecazatetracyclo[35.2.2.12,5.028,32]dotetraconta-1(40),3,5(42),37(41),38-pentaen-20-yl]acetic acid
SMILESCOc1ccc(C[C@@H]2NC(=O)[C@H](Cc3c[nH]cn3)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc3c[nH]c4ccc(F)cc34)NC(=O)[C@H](Cc3c[nH]c4ccc(F)cc34)NC(=O)[C@H](C)NC(=O)[C@H](NC(C)=O)CCc3cn(nn3)-c3ccc(cc3)C[C@@H](C(N)=O)NC(=O)C3(C)CCCN3C2=O)cc1
InChIInChI=1S/C68H75F2N17O13/c1-35-60(92)78-53(24-39-30-73-49-17-10-41(69)26-47(39)49)62(94)79-54(25-40-31-74-50-18-11-42(70)27-48(40)50)63(95)81-56(29-58(89)90)65(97)80-55(28-44-32-72-34-75-44)64(96)82-57(23-38-8-15-46(100-4)16-9-38)66(98)86-21-5-20-68(86,3)67(99)83-52(59(71)91)22-37-6-13-45(14-7-37)87-33-43(84-85-87)12-19-51(61(93)76-35)77-36(2)88/h6-11,13-18,26-27,30-35,51-57,73-74H,5,12,19-25,28-29H2,1-4H3,(H2,71,91)(H,72,75)(H,76,93)(H,77,88)(H,78,92)(H,79,94)(H,80,97)(H,81,95)(H,82,96)(H,83,99)(H,89,90)/t35-,51+,52-,53-,54-,55-,56-,57-,68?/m0/s1
InChIKeyAMADQZYKECSVOD-HQEIXELQSA-N
MW1376.45 g/mol
LogP0.96
Rot. Bonds13

About 2-[(8R,11S,14S,17S,20S,23S,26S,32S,35S)-8-acetamido-35-carbamoyl-14,17-bis[(5-fluoro-1H-indol-3-yl)methyl]-23-(1H-imidazol-4-ylmethyl)-26-[(4-methoxyphenyl)methyl]-11,32-dimethyl-9,12,15,18,21,24,27,33-octaoxo-2,3,4,10,13,16,19,22,25,28,34-undecazatetracyclo[35.2.2.12,5.028,32]dotetraconta-1(40),3,5(42),37(41),38-pentaen-20-yl]acetic acid

2-[(8R,11S,14S,17S,20S,23S,26S,32S,35S)-8-acetamido-35-carbamoyl-14,17-bis[(5-fluoro-1H-indol-3-yl)methyl]-23-(1H-imidazol-4-ylmethyl)-26-[(4-methoxyphenyl)methyl]-11,32-dimethyl-9,12,15,18,21,24,27,33-octaoxo-2,3,4,10,13,16,19,22,25,28,34-undecazatetracyclo[35.2.2.12,5.028,32]dotetraconta-1(40),3,5(42),37(41),38-pentaen-20-yl]acetic acid (PubChem CID 166611943) has the molecular formula C68H75F2N17O13 and a molecular weight of 1376.45 g/mol. Its IUPAC name is 2-[(8R,11S,14S,17S,20S,23S,26S,32S,35S)-8-acetamido-35-carbamoyl-14,17-bis[(5-fluoro-1H-indol-3-yl)methyl]-23-(1H-imidazol-4-ylmethyl)-26-[(4-methoxyphenyl)methyl]-11,32-dimethyl-9,12,15,18,21,24,27,33-octaoxo-2,3,4,10,13,16,19,22,25,28,34-undecazatetracyclo[35.2.2.12,5.028,32]dotetraconta-1(40),3,5(42),37(41),38-pentaen-20-yl]acetic acid.

Molecular Properties

Compound Name2-[(8R,11S,14S,17S,20S,23S,26S,32S,35S)-8-acetamido-35-carbamoyl-14,17-bis[(5-fluoro-1H-indol-3-yl)methyl]-23-(1H-imidazol-4-ylmethyl)-26-[(4-methoxyphenyl)methyl]-11,32-dimethyl-9,12,15,18,21,24,27,33-octaoxo-2,3,4,10,13,16,19,22,25,28,34-undecazatetracyclo[35.2.2.12,5.028,32]dotetraconta-1(40),3,5(42),37(41),38-pentaen-20-yl]acetic acid
PubChem CID166611943
Molecular FormulaC68H75F2N17O13
Molecular Weight1376.45 g/mol
Exact Mass1375.57
IUPAC Name2-[(8R,11S,14S,17S,20S,23S,26S,32S,35S)-8-acetamido-35-carbamoyl-14,17-bis[(5-fluoro-1H-indol-3-yl)methyl]-23-(1H-imidazol-4-ylmethyl)-26-[(4-methoxyphenyl)methyl]-11,32-dimethyl-9,12,15,18,21,24,27,33-octaoxo-2,3,4,10,13,16,19,22,25,28,34-undecazatetracyclo[35.2.2.12,5.028,32]dotetraconta-1(40),3,5(42),37(41),38-pentaen-20-yl]acetic acid
SMILESCOc1ccc(C[C@@H]2NC(=O)[C@H](Cc3c[nH]cn3)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc3c[nH]c4ccc(F)cc34)NC(=O)[C@H](Cc3c[nH]c4ccc(F)cc34)NC(=O)[C@H](C)NC(=O)[C@H](NC(C)=O)CCc3cn(nn3)-c3ccc(cc3)C[C@@H](C(N)=O)NC(=O)C3(C)CCCN3C2=O)cc1
InChIInChI=1S/C68H75F2N17O13/c1-35-60(92)78-53(24-39-30-73-49-17-10-41(69)26-47(39)49)62(94)79-54(25-40-31-74-50-18-11-42(70)27-48(40)50)63(95)81-56(29-58(89)90)65(97)80-55(28-44-32-72-34-75-44)64(96)82-57(23-38-8-15-46(100-4)16-9-38)66(98)86-21-5-20-68(86,3)67(99)83-52(59(71)91)22-37-6-13-45(14-7-37)87-33-43(84-85-87)12-19-51(61(93)76-35)77-36(2)88/h6-11,13-18,26-27,30-35,51-57,73-74H,5,12,19-25,28-29H2,1-4H3,(H2,71,91)(H,72,75)(H,76,93)(H,77,88)(H,78,92)(H,79,94)(H,80,97)(H,81,95)(H,82,96)(H,83,99)(H,89,90)/t35-,51+,52-,53-,54-,55-,56-,57-,68?/m0/s1
InChIKeyAMADQZYKECSVOD-HQEIXELQSA-N
XLogP0.96
TPSA433.70 Ų
H-Bond Donors13
H-Bond Acceptors16
Rotatable Bonds13
Heavy Atoms100
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001376.45
LogP ≤ 50.96
H-Bond Donors ≤ 513
H-Bond Acceptors ≤ 1016

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'crown_ether', 'substructure': 'N/A'}

Analyze 2-[(8R,11S,14S,17S,20S,23S,26S,32S,35S)-8-acetamido-35-carbamoyl-14,17-bis[(5-fluoro-1H-indol-3-yl)methyl]-23-(1H-imidazol-4-ylmethyl)-26-[(4-methoxyphenyl)methyl]-11,32-dimethyl-9,12,15,18,21,24,27,33-octaoxo-2,3,4,10,13,16,19,22,25,28,34-undecazatetracyclo[35.2.2.12,5.028,32]dotetraconta-1(40),3,5(42),37(41),38-pentaen-20-yl]acetic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[(8R,11S,14S,17S,20S,23S,26S,32S,35S)-8-acetamido-35-carbamoyl-14,17-bis[(5-fluoro-1H-indol-3-yl)methyl]-23-(1H-imidazol-4-ylmethyl)-26-[(4-methoxyphenyl)methyl]-11,32-dimethyl-9,12,15,18,21,24,27,33-octaoxo-2,3,4,10,13,16,19,22,25,28,34-undecazatetracyclo[35.2.2.12,5.028,32]dotetraconta-1(40),3,5(42),37(41),38-pentaen-20-yl]acetic acid?
The IUPAC name of 2-[(8R,11S,14S,17S,20S,23S,26S,32S,35S)-8-acetamido-35-carbamoyl-14,17-bis[(5-fluoro-1H-indol-3-yl)methyl]-23-(1H-imidazol-4-ylmethyl)-26-[(4-methoxyphenyl)methyl]-11,32-dimethyl-9,12,15,18,21,24,27,33-octaoxo-2,3,4,10,13,16,19,22,25,28,34-undecazatetracyclo[35.2.2.12,5.028,32]dotetraconta-1(40),3,5(42),37(41),38-pentaen-20-yl]acetic acid (CID 166611943) is 2-[(8R,11S,14S,17S,20S,23S,26S,32S,35S)-8-acetamido-35-carbamoyl-14,17-bis[(5-fluoro-1H-indol-3-yl)methyl]-23-(1H-imidazol-4-ylmethyl)-26-[(4-methoxyphenyl)methyl]-11,32-dimethyl-9,12,15,18,21,24,27,33-octaoxo-2,3,4,10,13,16,19,22,25,28,34-undecazatetracyclo[35.2.2.12,5.028,32]dotetraconta-1(40),3,5(42),37(41),38-pentaen-20-yl]acetic acid.
What is the SMILES notation for 2-[(8R,11S,14S,17S,20S,23S,26S,32S,35S)-8-acetamido-35-carbamoyl-14,17-bis[(5-fluoro-1H-indol-3-yl)methyl]-23-(1H-imidazol-4-ylmethyl)-26-[(4-methoxyphenyl)methyl]-11,32-dimethyl-9,12,15,18,21,24,27,33-octaoxo-2,3,4,10,13,16,19,22,25,28,34-undecazatetracyclo[35.2.2.12,5.028,32]dotetraconta-1(40),3,5(42),37(41),38-pentaen-20-yl]acetic acid?
The canonical SMILES for 2-[(8R,11S,14S,17S,20S,23S,26S,32S,35S)-8-acetamido-35-carbamoyl-14,17-bis[(5-fluoro-1H-indol-3-yl)methyl]-23-(1H-imidazol-4-ylmethyl)-26-[(4-methoxyphenyl)methyl]-11,32-dimethyl-9,12,15,18,21,24,27,33-octaoxo-2,3,4,10,13,16,19,22,25,28,34-undecazatetracyclo[35.2.2.12,5.028,32]dotetraconta-1(40),3,5(42),37(41),38-pentaen-20-yl]acetic acid is COc1ccc(C[C@@H]2NC(=O)[C@H](Cc3c[nH]cn3)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc3c[nH]c4ccc(F)cc34)NC(=O)[C@H](Cc3c[nH]c4ccc(F)cc34)NC(=O)[C@H](C)NC(=O)[C@H](NC(C)=O)CCc3cn(nn3)-c3ccc(cc3)C[C@@H](C(N)=O)NC(=O)C3(C)CCCN3C2=O)cc1.
What is the InChIKey of 2-[(8R,11S,14S,17S,20S,23S,26S,32S,35S)-8-acetamido-35-carbamoyl-14,17-bis[(5-fluoro-1H-indol-3-yl)methyl]-23-(1H-imidazol-4-ylmethyl)-26-[(4-methoxyphenyl)methyl]-11,32-dimethyl-9,12,15,18,21,24,27,33-octaoxo-2,3,4,10,13,16,19,22,25,28,34-undecazatetracyclo[35.2.2.12,5.028,32]dotetraconta-1(40),3,5(42),37(41),38-pentaen-20-yl]acetic acid?
The InChIKey is AMADQZYKECSVOD-HQEIXELQSA-N. The full InChI is InChI=1S/C68H75F2N17O13/c1-35-60(92)78-53(24-39-30-73-49-17-10-41(69)26-47(39)49)62(94)79-54(25-40-31-74-50-18-11-42(70)27-48(40)50)63(95)81-56(29-58(89)90)65(97)80-55(28-44-32-72-34-75-44)64(96)82-57(23-38-8-15-46(100-4)16-9-38)66(98)86-21-5-20-68(86,3)67(99)83-52(59(71)91)22-37-6-13-45(14-7-37)87-33-43(84-85-87)12-19-51(61(93)76-35)77-36(2)88/h6-11,13-18,26-27,30-35,51-57,73-74H,5,12,19-25,28-29H2,1-4H3,(H2,71,91)(H,72,75)(H,76,93)(H,77,88)(H,78,92)(H,79,94)(H,80,97)(H,81,95)(H,82,96)(H,83,99)(H,89,90)/t35-,51+,52-,53-,54-,55-,56-,57-,68?/m0/s1.
What are the key properties of 2-[(8R,11S,14S,17S,20S,23S,26S,32S,35S)-8-acetamido-35-carbamoyl-14,17-bis[(5-fluoro-1H-indol-3-yl)methyl]-23-(1H-imidazol-4-ylmethyl)-26-[(4-methoxyphenyl)methyl]-11,32-dimethyl-9,12,15,18,21,24,27,33-octaoxo-2,3,4,10,13,16,19,22,25,28,34-undecazatetracyclo[35.2.2.12,5.028,32]dotetraconta-1(40),3,5(42),37(41),38-pentaen-20-yl]acetic acid?
2-[(8R,11S,14S,17S,20S,23S,26S,32S,35S)-8-acetamido-35-carbamoyl-14,17-bis[(5-fluoro-1H-indol-3-yl)methyl]-23-(1H-imidazol-4-ylmethyl)-26-[(4-methoxyphenyl)methyl]-11,32-dimethyl-9,12,15,18,21,24,27,33-octaoxo-2,3,4,10,13,16,19,22,25,28,34-undecazatetracyclo[35.2.2.12,5.028,32]dotetraconta-1(40),3,5(42),37(41),38-pentaen-20-yl]acetic acid has a molecular weight of 1376.45 g/mol, XLogP of 0.96, 13 rotatable bonds, 13 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(8R,11S,14S,17S,20S,23S,26S,32S,35S)-8-acetamido-35-carbamoyl-14,17-bis[(5-fluoro-1H-indol-3-yl)methyl]-23-(1H-imidazol-4-ylmethyl)-26-[(4-methoxyphenyl)methyl]-11,32-dimethyl-9,12,15,18,21,24,27,33-octaoxo-2,3,4,10,13,16,19,22,25,28,34-undecazatetracyclo[35.2.2.12,5.028,32]dotetraconta-1(40),3,5(42),37(41),38-pentaen-20-yl]acetic acid is sourced from PubChem (CID 166611943), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).